Products

Cutting-Edge AI Technologies Ready to Change the Landscape in Gynecology Practice
Wide scope in gynecological healthcare, comprising both reproductive and gynecologic tracts.

AI & Software

Breaking barriers for women access in healthcare

Each year, millions of women worldwide experience gynecological challenges. However, a concerning number of these women face significant barriers in accessing reliable and readily available diagnostic technologies. This lack of access often results in delays in critical diagnoses, which ultimately leads to suboptimal patient outcomes and potentially limiting early intervention opportunities.

Powered by a constantly learning AI, our innovative analysis tool (GynAIcare) offers ever-increasing accuracy, leading to more confident diagnoses for patients.

Advancing the frontier of women's health.

AI-powered platform ensuring over 95% accuracy in detecting and differentiating a wide range of relevant lesions lesions across the female genital tract. With immense potential to minimize diagnostic errors, accelerate the examination process.

By leveraging the power of AI-driven technology, GynAICare aims to bridge the existing gap in women’s healthcare. This innovative platform empowers both healthcare professionals and women themselves by fostering early and accurate diagnoses, facilitating informed decision-making, and ultimately, building a stronger foundation for optimal health outcomes.
GynAICare provides a variety of benefits for patients and healthcare professionals:

Diagnostic precision and efficiency in cancer detection.

HisterAIscope® uses cutting-edge AI algorithms for real-time detection and characterization of uterine lesions during hysteroscopy, promising heightened diagnostic precision and efficiency in cancer detection.

HisterAIscope® is not just a technology; it is an ally in making informed clinical decisions, ensuring that each diagnosis is conducted with highest precision. This advancement in endometrial lesion assessment not only enriches medical practice but also stands out as a vital tool in promoting the health and well-being of women.

Stay updated

Get the latest developments from our AI technologies by subscribing to our newsletter

Related articles

Exciting news from DigestAID! Our team is thrilled to be showcasing at the 19th ECCO
Thrilled to share that DigestAID’s impactful work is making waves!
The detection of anal squamous cell cancer precursors with high-resolution anoscopy (HRA) poses a medical challenge, with a significant subset of lesions often missed